查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511312

到 2030 年高性能医用塑胶的全球市场预测：按原材料、应用和地区划分

High Performance Medical Plastics Market Forecasts to 2030 - Global Analysis By Raw Material, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2024年全球高性能医用塑胶市场规模将达11.5亿美元，预计2030年将达到20.8亿美元，预测期内复合年增长率为10.4%。

高性能医用塑胶是专门为满足医疗应用的严格要求而设计的先进聚合物材料。这些材料具有卓越的强度、耐用性和生物相容性，非常适合用于医疗设备、植入和手术器械。高性能医用塑胶具有耐灭菌方法、与各种体液相容以及精密成型能力等特性，可製造复杂且可靠的医疗设备。

根据世界卫生组织 2021 年的数据，每年约有 130 万人死于交通事故，另有 2,000 至 5,000 万人遭受非致命伤害，其中许多人因受伤而残疾。

环境永续性意识不断增强

随着人们对传统塑胶对生态影响的认识不断增强，包括医疗保健在内的行业正在转向永续的替代品。高性能医用塑胶以其耐用性、生物相容性和灭菌能力而闻名，正在迅速被采用。这些材料提供了引人注目的解决方案，满足医疗保健行业严格的品质和安全标准，同时最大限度地减少对环境的影响。製造商正在投资研发，以进一步增强这些塑胶的永续性，从而推动市场成长。

材料缺陷的风险

高性能医用塑胶 (HPMP) 的进步受到材料失效风险的挑战。这些材料由于具有生物相容性、耐用性和耐化学性等优异特性，在各种医疗应用中极为重要。确保医疗应用恶劣条件下的可靠性至关重要。然而，材料失效可能会导致性能下降、潜在的患者伤害以及製造商成本增加。长期接触刺激性化学物质、重复灭菌程序以及使用过程中的机械应力等因素会导致失败的风险。

开发患者专用植入

患者专用植入的开发是高性能医用塑胶兴起的主要动力。这些植入根据个别患者的解剖规格量身定制，与传统的通用植入相比，具有卓越的贴合性和性能。高性能医用塑胶因其多功能性、生物相容性和耐用性而在这种定製过程中发挥关键作用。这些材料可以经过精确设计来模仿人体组织的特性，确保在体内达到最佳整合，同时提供必要的结构支撑。其他优点包括轻质设计、耐腐蚀和灵活性，使其成为各种医疗应用的理想选择。

成本限制

成本限制是高性能医用塑胶进步的主要障碍。这些材料通常需要特殊的配方和製造工艺，以满足医疗产业严格的安全和性能标准。在降低成本的同时达到这些标准是一项重大挑战。优质的原材料、精密的製造流程以及严格的品管措施都导致了更高的製造成本。因此，具有卓越性能的创新医用塑胶的开发和采用可能会因平衡负担能力和功能性的需要而受到限制。

COVID-19 的影响：

COVID-19大流行对高性能医用塑胶市场产生了重大影响，因为对人工呼吸器、面罩和医用包装等医疗设备的需求激增，导致其生产中使用的高性能医用塑胶得到提振。 。然而，由于关闭和限製而导致的全球供应链中断给原材料采购和生产能力带来了挑战。整体而言，疫情带来了挑战，但也加速了创新，凸显了高性能医用塑胶在医疗保健应用中的重要角色。

预计聚砜市场在预测期内将成为最大的细分市场

预计聚砜领域在预测期内将占据最大份额。聚砜是一种高性能热塑性塑料，由于其优异的性能正在彻底改变医用塑胶市场。其优异的强度、耐化学性和生物相容性使其成为各种医疗应用的理想选择。在手术器械、导管和血液透析机膜等医疗设备中，聚砜具有无与伦比的耐用性和可靠性。它们能够承受重复的灭菌週期而不会劣化，确保产品的使用寿命和安全性，这在医疗保健环境中至关重要。

预计药物输送产业在预测期内复合年增长率最高

预计药物输送产业在预测期内复合年增长率最高。高性能医用塑胶以其生物相容性、耐用性和多功能性而闻名，是药物传输系统的理想材料。这些塑胶可以经过精确设计，以更高的效率和精度封装和输送药物。此外，实现标靶药物传输可以最大限度地减少全身副作用并改善患者的治疗结果。先进的製造技术能够生产复杂的药物输送装置，例如根据特定治疗需求量身定制的植入、微球和贴片。

比最大的地区

塑胶零件越来越多地用于医疗设备，因为它们比金属和玻璃等传统材料更通用、更轻且更具成本效益。医疗技术的进步要求材料能够满足严格的监管标准，同时具有卓越的性能，例如生物相容性、耐用性和耐灭菌製程。此外，高性能医用塑胶符合这些标准，这使得它们对于製造从导管到手术器械等各种医疗设备至关重要。

复合年增长率最高的地区：

预计亚太地区在预测期内将出现强劲成长。严格的法规要求在医疗设备和设备中使用安全、优质的材料，这促使製造商选择先进的医疗级塑胶。这些法规确保医疗设备符合严格的安全和性能标准，推动该地区对高性能医用塑胶的需求。专注于减少医疗保健相关感染的监管工作正在刺激抗菌和无菌塑胶在医疗应用中的采用。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球高性能医用塑胶市场：依原料划分

  • 聚砜
  • 聚丙烯
  • 聚碳酸酯
  • 聚苯硫
  • 其他的

第六章 全球高性能医用塑胶市场：依应用分类

  • 药物输送
  • 义肢/植入
  • 医疗设备/工具
  • 医疗抛弃式
  • 其他的

第七章 全球高性能医用塑胶市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第八章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第九章 公司概况

  • BASF SE
  • Bayer AG
  • DuPont
  • Eastman Chemical Company
  • Evonik Industries AG
  • Lubrizol Corporation
  • Mitsubishi Chemical Corporation
  • Raumedic AG
  • Rochling SE & Co. KG
  • Saint-Gobain Performance Plastic
  • The Chemours Company
  • Victrex PLC
Product Code: SMRC26690

According to Stratistics MRC, the Global High Performance Medical Plastics Market is accounted for $1.15 billion in 2024 and is expected to reach $2.08 billion by 2030 growing at a CAGR of 10.4% during the forecast period. High-performance medical plastics are advanced polymer materials specifically engineered to meet stringent requirements for medical applications. These materials exhibit exceptional strength, durability, and biocompatibility, making them ideal for use in medical devices, implants, and surgical instruments. High-performance medical plastics offer properties such as resistance to sterilization methods, compatibility with various bodily fluids, and precision molding capabilities, enabling the creation of intricate and reliable medical devices.

According to the WHO 2021, around 1.3 million people die each year due to road traffic crashes and around 20 to 50 million more people suffer non-fatal injuries, with many experiencing a disability due to their injury.

Market Dynamics:

Driver:

Increasing awareness about environmental sustainability

With increasing awareness about the ecological repercussions of traditional plastics, industries, including healthcare, are pivoting towards sustainable alternatives. High performance medical plastics, renowned for their durability, biocompatibility, and sterilization capabilities, are witnessing a surge in adoption. These materials offer a compelling solution, aligning with the healthcare sector's stringent quality and safety standards while minimizing environmental impact. Manufacturers are investing in research and development to enhance the sustainability profile of these plastics further, catalyzing market growth.

Restraint:

Risk of material failure

The risk of material failure poses a significant challenge to the advancement of High Performance Medical Plastics (HPMP). These materials are crucial in various medical applications due to their superior properties like biocompatibility, durability, and resistance to chemicals. Ensuring their reliability under the demanding conditions of medical use is essential. However, material failures can lead to compromised performance, potential harm to patients, and increased costs for manufacturers. Factors such as long-term exposure to harsh chemicals, repeated sterilization processes, and mechanical stresses during use contribute to the risk of failure.

Opportunity:

Development of patient specific implants

The development of patient-specific implants has been a significant driving force behind the rise of high-performance medical plastics. These implants are tailored to individual patients' anatomical specifications, offering better compatibility and performance compared to traditional, one-size-fits-all implants. High-performance medical plastics play a crucial role in this customization process due to their versatility, biocompatibility, and durability. These materials can be precisely engineered to mimic the properties of human tissues, ensuring optimal integration within the body while providing necessary structural support. Additionally, they offer advantages such as lightweight design, resistance to corrosion, and flexibility, making them ideal for a wide range of medical applications.

Threat:

Cost constraints

Cost constraints pose a significant hindrance to the advancement of high-performance medical plastics. These materials often require specialized formulations and production processes to meet stringent safety and performance standards demanded by the medical industry. Achieving these standards while keeping costs low presents a considerable challenge. High-quality raw materials, precise manufacturing techniques, and rigorous quality control measures all contribute to elevated production expenses. As a result, the development and adoption of innovative medical plastics with superior performance characteristics may be limited by the need to balance affordability with functionality.

Covid-19 Impact:

The Covid-19 pandemic has significantly impacted the High Performance Medical Plastics market due to the surge in demand for medical equipment such as ventilators, face shields, and medical packaging has boosted the demand for high-performance medical plastics used in their manufacturing. However, disruptions in the global supply chain due to lockdowns and restrictions have led to challenges in sourcing raw materials and hindered production capacities. Overall, while the pandemic has posed challenges, it has also accelerated innovation and highlighted the critical role of high-performance medical plastics in healthcare applications.

The Polysulfone segment is expected to be the largest during the forecast period

Polysulfone segment is expected to be the largest during the forecast period. Polysulfone, a high-performance thermoplastic, is revolutionizing the medical plastics market due to its exceptional properties. Its superior strength, chemical resistance, and biocompatibility make it ideal for various medical applications. In medical devices, such as surgical instruments, catheters, and hemodialysis membranes, polysulfone offers unmatched durability and reliability. Its ability to withstand repeated sterilization cycles without degradation ensures product longevity and safety, crucial in healthcare settings.

The Drug Delivery segment is expected to have the highest CAGR during the forecast period

Drug Delivery segment is expected to have the highest CAGR during the forecast period. High performance medical plastics, known for their biocompatibility, durability, and versatility, serve as ideal materials for drug delivery systems. These plastics can be precisely engineered to encapsulate and deliver pharmaceuticals with increased efficiency and accuracy. Moreover, they enable targeted drug delivery, minimizing systemic side effects and improving patient outcomes. Advanced manufacturing techniques allow for the production of intricate drug delivery devices, such as implants, microspheres, and patches, tailored to specific therapeutic needs.

Region with largest share:

North America region commanded the largest share of the market during the extrapolated period, as medical devices are increasingly incorporating plastic components due to their versatility, lightweight nature, and cost-effectiveness compared to traditional materials like metal or glass. The advancements in medical technology require materials that can meet stringent regulatory standards while offering superior performance characteristics such as biocompatibility, durability, and resistance to sterilization processes. Furthermore, high-performance medical plastics fulfill these criteria, making them indispensable in the production of various medical devices ranging from catheters to surgical instruments.

Region with highest CAGR:

Asia Pacific region is estimated to witness robust growth over the projection time frame. Stringent regulations mandating the use of safe and high-quality materials in medical devices and equipment are prompting manufacturers to opt for advanced medical-grade plastics. These regulations ensure that medical devices meet strict safety and performance standards, driving the demand for high-performance medical plastics in the region. Regulatory initiatives focused on reducing healthcare-associated infections are spurring the adoption of antimicrobial and sterilizable plastics in medical applications.

Key players in the market

Some of the key players in High Performance Medical Plastics market include BASF SE, Bayer AG, DuPont, Eastman Chemical Company, Evonik Industries AG, Lubrizol Corporation, Mitsubishi Chemical Corporation, Raumedic AG, Rochling SE & Co. KG, Saint-Gobain Performance Plastic, The Chemours Company and Victrex PLC.

Key Developments:

In March2024, Evonik Industries AG and Vland Biotech Begin Joint Venture. The venture aims to expand the market presence of their livestock probiotics in Greater China and develop new products. Evonik's biotech platform is dedicated to creating biosolutions for healthier living. It innovates at the crossroads of chemistry, biotechnology, pharmacology, and data science.

In June2023, The Lubrizol Corporation will invest over $150 million (about ₹1,200 crore) across different projects in India. According to the specialty chemicals maker, the investments will be made into setting up CPVC (chlorinated polyvinyl chloride) resin plant in Vilayat, doubling the capacity at its site in Dahej in Gujarat and opening a grease lab in Navi Mumbai.

Raw Materials Covered:

  • Polysulfone
  • Polypropylene
  • Polycarbonate
  • Polyphenylene Sulfide
  • Other Raw Materials

Applications Covered:

  • Drug Delivery
  • Prosthetics & Implants
  • Medical Equipment & Tools
  • Medical Disposables
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global High Performance Medical Plastics Market, By Raw Material

  • 5.1 Introduction
  • 5.2 Polysulfone
  • 5.3 Polypropylene
  • 5.4 Polycarbonate
  • 5.5 Polyphenylene Sulfide
  • 5.6 Other Raw Materials

6 Global High Performance Medical Plastics Market, By Application

  • 6.1 Introduction
  • 6.2 Drug Delivery
  • 6.3 Prosthetics & Implants
  • 6.4 Medical Equipment & Tools
  • 6.5 Medical Disposables
  • 6.6 Other Applications

7 Global High Performance Medical Plastics Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 BASF SE
  • 9.2 Bayer AG
  • 9.3 DuPont
  • 9.4 Eastman Chemical Company
  • 9.5 Evonik Industries AG
  • 9.6 Lubrizol Corporation
  • 9.7 Mitsubishi Chemical Corporation
  • 9.8 Raumedic AG
  • 9.9 Rochling SE & Co. KG
  • 9.10 Saint-Gobain Performance Plastic
  • 9.11 The Chemours Company
  • 9.12 Victrex PLC

List of Tables

  • Table 1 Global High Performance Medical Plastics Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global High Performance Medical Plastics Market Outlook, By Raw Material (2022-2030) ($MN)
  • Table 3 Global High Performance Medical Plastics Market Outlook, By Polysulfone (2022-2030) ($MN)
  • Table 4 Global High Performance Medical Plastics Market Outlook, By Polypropylene (2022-2030) ($MN)
  • Table 5 Global High Performance Medical Plastics Market Outlook, By Polycarbonate (2022-2030) ($MN)
  • Table 6 Global High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (2022-2030) ($MN)
  • Table 7 Global High Performance Medical Plastics Market Outlook, By Other Raw Materials (2022-2030) ($MN)
  • Table 8 Global High Performance Medical Plastics Market Outlook, By Application (2022-2030) ($MN)
  • Table 9 Global High Performance Medical Plastics Market Outlook, By Drug Delivery (2022-2030) ($MN)
  • Table 10 Global High Performance Medical Plastics Market Outlook, By Prosthetics & Implants (2022-2030) ($MN)
  • Table 11 Global High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2022-2030) ($MN)
  • Table 12 Global High Performance Medical Plastics Market Outlook, By Medical Disposables (2022-2030) ($MN)
  • Table 13 Global High Performance Medical Plastics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 14 North America High Performance Medical Plastics Market Outlook, By Country (2022-2030) ($MN)
  • Table 15 North America High Performance Medical Plastics Market Outlook, By Raw Material (2022-2030) ($MN)
  • Table 16 North America High Performance Medical Plastics Market Outlook, By Polysulfone (2022-2030) ($MN)
  • Table 17 North America High Performance Medical Plastics Market Outlook, By Polypropylene (2022-2030) ($MN)
  • Table 18 North America High Performance Medical Plastics Market Outlook, By Polycarbonate (2022-2030) ($MN)
  • Table 19 North America High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (2022-2030) ($MN)
  • Table 20 North America High Performance Medical Plastics Market Outlook, By Other Raw Materials (2022-2030) ($MN)
  • Table 21 North America High Performance Medical Plastics Market Outlook, By Application (2022-2030) ($MN)
  • Table 22 North America High Performance Medical Plastics Market Outlook, By Drug Delivery (2022-2030) ($MN)
  • Table 23 North America High Performance Medical Plastics Market Outlook, By Prosthetics & Implants (2022-2030) ($MN)
  • Table 24 North America High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2022-2030) ($MN)
  • Table 25 North America High Performance Medical Plastics Market Outlook, By Medical Disposables (2022-2030) ($MN)
  • Table 26 North America High Performance Medical Plastics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 27 Europe High Performance Medical Plastics Market Outlook, By Country (2022-2030) ($MN)
  • Table 28 Europe High Performance Medical Plastics Market Outlook, By Raw Material (2022-2030) ($MN)
  • Table 29 Europe High Performance Medical Plastics Market Outlook, By Polysulfone (2022-2030) ($MN)
  • Table 30 Europe High Performance Medical Plastics Market Outlook, By Polypropylene (2022-2030) ($MN)
  • Table 31 Europe High Performance Medical Plastics Market Outlook, By Polycarbonate (2022-2030) ($MN)
  • Table 32 Europe High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (2022-2030) ($MN)
  • Table 33 Europe High Performance Medical Plastics Market Outlook, By Other Raw Materials (2022-2030) ($MN)
  • Table 34 Europe High Performance Medical Plastics Market Outlook, By Application (2022-2030) ($MN)
  • Table 35 Europe High Performance Medical Plastics Market Outlook, By Drug Delivery (2022-2030) ($MN)
  • Table 36 Europe High Performance Medical Plastics Market Outlook, By Prosthetics & Implants (2022-2030) ($MN)
  • Table 37 Europe High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2022-2030) ($MN)
  • Table 38 Europe High Performance Medical Plastics Market Outlook, By Medical Disposables (2022-2030) ($MN)
  • Table 39 Europe High Performance Medical Plastics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 40 Asia Pacific High Performance Medical Plastics Market Outlook, By Country (2022-2030) ($MN)
  • Table 41 Asia Pacific High Performance Medical Plastics Market Outlook, By Raw Material (2022-2030) ($MN)
  • Table 42 Asia Pacific High Performance Medical Plastics Market Outlook, By Polysulfone (2022-2030) ($MN)
  • Table 43 Asia Pacific High Performance Medical Plastics Market Outlook, By Polypropylene (2022-2030) ($MN)
  • Table 44 Asia Pacific High Performance Medical Plastics Market Outlook, By Polycarbonate (2022-2030) ($MN)
  • Table 45 Asia Pacific High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (2022-2030) ($MN)
  • Table 46 Asia Pacific High Performance Medical Plastics Market Outlook, By Other Raw Materials (2022-2030) ($MN)
  • Table 47 Asia Pacific High Performance Medical Plastics Market Outlook, By Application (2022-2030) ($MN)
  • Table 48 Asia Pacific High Performance Medical Plastics Market Outlook, By Drug Delivery (2022-2030) ($MN)
  • Table 49 Asia Pacific High Performance Medical Plastics Market Outlook, By Prosthetics & Implants (2022-2030) ($MN)
  • Table 50 Asia Pacific High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2022-2030) ($MN)
  • Table 51 Asia Pacific High Performance Medical Plastics Market Outlook, By Medical Disposables (2022-2030) ($MN)
  • Table 52 Asia Pacific High Performance Medical Plastics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 53 South America High Performance Medical Plastics Market Outlook, By Country (2022-2030) ($MN)
  • Table 54 South America High Performance Medical Plastics Market Outlook, By Raw Material (2022-2030) ($MN)
  • Table 55 South America High Performance Medical Plastics Market Outlook, By Polysulfone (2022-2030) ($MN)
  • Table 56 South America High Performance Medical Plastics Market Outlook, By Polypropylene (2022-2030) ($MN)
  • Table 57 South America High Performance Medical Plastics Market Outlook, By Polycarbonate (2022-2030) ($MN)
  • Table 58 South America High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (2022-2030) ($MN)
  • Table 59 South America High Performance Medical Plastics Market Outlook, By Other Raw Materials (2022-2030) ($MN)
  • Table 60 South America High Performance Medical Plastics Market Outlook, By Application (2022-2030) ($MN)
  • Table 61 South America High Performance Medical Plastics Market Outlook, By Drug Delivery (2022-2030) ($MN)
  • Table 62 South America High Performance Medical Plastics Market Outlook, By Prosthetics & Implants (2022-2030) ($MN)
  • Table 63 South America High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2022-2030) ($MN)
  • Table 64 South America High Performance Medical Plastics Market Outlook, By Medical Disposables (2022-2030) ($MN)
  • Table 65 South America High Performance Medical Plastics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 66 Middle East & Africa High Performance Medical Plastics Market Outlook, By Country (2022-2030) ($MN)
  • Table 67 Middle East & Africa High Performance Medical Plastics Market Outlook, By Raw Material (2022-2030) ($MN)
  • Table 68 Middle East & Africa High Performance Medical Plastics Market Outlook, By Polysulfone (2022-2030) ($MN)
  • Table 69 Middle East & Africa High Performance Medical Plastics Market Outlook, By Polypropylene (2022-2030) ($MN)
  • Table 70 Middle East & Africa High Performance Medical Plastics Market Outlook, By Polycarbonate (2022-2030) ($MN)
  • Table 71 Middle East & Africa High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (2022-2030) ($MN)
  • Table 72 Middle East & Africa High Performance Medical Plastics Market Outlook, By Other Raw Materials (2022-2030) ($MN)
  • Table 73 Middle East & Africa High Performance Medical Plastics Market Outlook, By Application (2022-2030) ($MN)
  • Table 74 Middle East & Africa High Performance Medical Plastics Market Outlook, By Drug Delivery (2022-2030) ($MN)
  • Table 75 Middle East & Africa High Performance Medical Plastics Market Outlook, By Prosthetics & Implants (2022-2030) ($MN)
  • Table 76 Middle East & Africa High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2022-2030) ($MN)
  • Table 77 Middle East & Africa High Performance Medical Plastics Market Outlook, By Medical Disposables (2022-2030) ($MN)
  • Table 78 Middle East & Africa High Performance Medical Plastics Market Outlook, By Other Applications (2022-2030) ($MN)